Study guide
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium
Key Takeaways Explain This Topic AI
In non-lactating patients ovulation can occur as early as day 21 to 28 postpartum, with a mean near 45 days, and it precedes the first menstrual period in more than half of cases.
The lactational amenorrhea method requires all three criteria simultaneously: near-exclusive breastfeeding with intervals no longer than 4 hours by day and 6 hours by night, amenorrhea after day 56, and infant under 6 months.
Combined hormonal contraception is US MEC Category 4 for everyone before 21 days postpartum because of venous thromboembolism risk.
Progestin-only pills, the implant, and DMPA are US MEC Category 1 immediately postpartum for both lactating and non-lactating patients.
Diaphragms and cervical caps are Category 4 before 6 weeks postpartum and require formal refitting after involution is complete.
Last updated: September 2026
Optimizing interpregnancy intervals (the American College of Obstetricians and Gynecologists [ACOG] recommends avoiding interpregnancy intervals shorter than 18 months) dramatically reduces the risks of preterm birth, low birth weight, small-for-gestational-age infants, and maternal morbidity. Providing comprehensive, non-coercive, person-centered postpartum contraceptive counseling that respects patient autonomy is a core competency of certified nurse-midwives. Mastery of postpartum ovulation kinetics, the CDC Medical Eligibility Criteria for Contraceptive Use (US MEC), immediate postpartum long-acting reversible contraception (LARC) protocols, and federal sterilization regulations is required for clinical practice and AMCB examination success.
Return of Fertility & Ovulation Timeline
Understanding the physiological return of fertility is essential for dispelling widespread patient misconceptions regarding postpartum sterility: Ovulation & Fertility Resumption Postpartum
─────────────────────────────────────────────────────────────────────────────
Non-Lactating Individuals:
- Earliest ovulation: Day 21 to 28 postpartum
- Mean time to ovulation: ~45 days postpartum (range: 25–70 days)
- Return of menses: Typically by 6 to 12 weeks postpartum
- Clinical Rule: Fertile ovulation PRECEDES the first menstrual period!
Lactating Individuals:
- Mechanism: Hyperprolactinemic anovulation via GnRH suppression
- Timing: Highly variable; delayed as long as suckling is frequent
- Vulnerability: Ovulation returns as intervals widen (>4h day, >6h night)
- ─────────────────────────────────────────────────────────────────────────────
- Non-Lactating Individuals
In the absence of infant suckling, maternal serum prolactin levels decline rapidly, returning to nonpregnant baseline concentrations by postpartum weeks 2 to 3 . Follicle-stimulating hormone (FSH) concentrations rebound, stimulating follicular recruitment within the ovaries.
Earliest Ovulation: Can occur as early as postpartum day 21 to 28 .
Mean Time to Ovulation: Approximately 45 days (range 25 to 70 days).
Clinical Rule: In over 50% of non-lactating women , the first ovulation precedes the first menstrual bleeding episode and is capable of fertilization and implantation. Contraceptive counseling must begin antepartum and a reliable method should be initiated prior to postpartum day 21 .
Lactating Individuals
Frequent, round-the-clock infant suckling generates pulsatile neural signals that suppress the hypothalamic pulse generator of gonadotropin-releasing hormone (GnRH) . In the absence of pulsatile GnRH, the anterior pituitary is unable to secrete normal pulsatile bursts of luteinizing hormone (LH) and FSH, preventing follicular maturation and eliminating the preovulatory LH surge. This state of hyperprolactinemic anovulatory amenorrhea provides natural contraception, provided suckling intensity remains high. However, as supplemental feedings, pumping, or prolonged nighttime infant sleep intervals (>6 hours) are introduced, prolactin surges diminish, and fertile ovulation resumes unpredictably prior to menses.
The Lactational Amenorrhea Method (LAM)
The Lactational Amenorrhea Method (LAM) is an evidence-based, modern family planning method founded on infant feeding-induced anovulation. It is not merely "breastfeeding," but requires adherence to three rigid, co-dependent criteria:
The Three Mandatory Diagnostic Criteria
To rely on LAM for contraception, the patient must meet ALL THREE of the following criteria simultaneously:
Exclusive or Near-Exclusive Breastfeeding: The infant must receive >85% to 90% of all caloric intake directly from the breast (or pumped breast milk on an identical schedule). Feedings must occur on demand, with intervals not exceeding 4 hours during the daytime and not exceeding 6 hours at night . No regular supplementation with infant formula, water, glucose water, or solid foods is permitted.
Complete Maternal Amenorrhea: The mother must have experienced no vaginal bleeding or spotting after 56 days (8 weeks) postpartum . Any bleeding occurring on or after postpartum day 56—regardless of duration or volume—is clinically treated as return of menses, signaling potential follicular development.
Infant Age Less Than 6 Months: The infant must be younger than 6 months of age . Beyond 6 months, infant developmental milestones mandate the introduction of complementary solid foods, which inherently decreases suckling frequency and triggers ovulation resumption.
Contraceptive Efficacy & Midwifery Counseling
When all three criteria are strictly fulfilled, LAM confers a contraceptive failure rate of less than 2% (98% efficacy) , rivaling oral contraceptive pills. However, the midwife must provide anticipatory guidance: the moment any single criterion is breached (e.g., infant sleeps 7 hours at night, formula supplementation begins, spotting occurs after day 56, or the infant reaches 6 months of age), LAM is instantly void, and the patient must immediately transition to another compatible contraceptive method without delay.
CDC Medical Eligibility Criteria (US MEC) in the Puerperium
The CDC publishes the U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC) , stratifying safety into four numerical categories:
Category 1: No restriction; the method can be used under any circumstances.
Category 2: Advantages of using the method generally outweigh theoretical or proven risks.
Category 3: Theoretical or proven risks usually outweigh advantages; method not recommended unless other methods unavailable or unacceptable.
Category 4: Unacceptable health risk; the method is strictly contraindicated .
Master US MEC Contraceptive Timing Table
Contraceptive Method <21 Days Postpartum (Non-BF) <21 Days Postpartum (BF) 21–42 Days Postpartum (No VTE Risks) 21–42 Days Postpartum (With VTE Risks) 21–42 Days Postpartum (BF) >42 Days Postpartum (>6 Weeks)
Combined Hormonal (COCs, Patch, Ring) Category 4 Category 4 Category 2 Category 3 Category 3 Category 1 (Cat 2 if high VTE risk)
- Progestin-Only Pills (POPs) Category 1 Category 1 (or 2) Category 1 Category 1 Category 1 Category 1
- Etonogestrel Subdermal Implant Category 1 Category 1 (or 2) Category 1 Category 1 Category 1 Category 1
- DMPA Injection (Depo-Provera) Category 1 Category 1 (or 2) Category 1 Category 1 Category 1 Category 1
Copper IUD (ParaGard) Category 1 (<10 min / <48h) Category 1 (<10 min / <48h) Category 2 (48h to <4w) Category 2 (48h to <4w) Category 2 (48h to <4w) Category 1 (≥4 weeks)
LNG-IUD (Mirena, Kyleena, Liletta) Category 1 / 2 (<10 min / <48h) Category 1 / 2 (<10 min / <48h) Category 2 (48h to <4w) Category 2 (48h to <4w) Category 2 (48h to <4w) Category 1 (≥4 weeks)
Diaphragm / Cervical Cap Category 4 Category 4 Category 4 Category 4 Category 4 Category 1 (requires refitting)
Male / Female Condoms Category 1 Category 1 Category 1 Category 1 Category 1 Category 1
Note: US MEC designates progestin-only methods as Category 2 for breastfeeding individuals <1 month postpartum in conservative guidelines due to theoretical concerns regarding neonatal steroid metabolism; however, ACOG and extensive global evidence endorse immediate postpartum initiation (Category 1) prior to discharge.